This week, Caroline Hyde sat down with Allergan Chief Executive Brent Saunders for a wide-ranging interview as part of our CEO Spotlight Series. Saunders discussed high drug prices, selling Allergan to rival AbbVie for $63 billion, why his best career decision was taking a "huge" pay cut and what's coming next for him after the AbbVie deal.
 Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

This week, Caroline Hyde sat down with Allergan Chief Executive Brent Saunders for a wide-ranging interview as part of our CEO Spotlight Series. Saunders discussed high drug prices, selling Allergan to rival AbbVie for $63 billion, why his best career decision was taking a "huge" pay cut and what's coming next for him after the AbbVie deal. Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

This week, Caroline Hyde sat down with Allergan&nbsp;Chief Executive Brent Saunders for a wide-ranging interview as part of our CEO Spotlight Series. Saunders&nbsp;discussed high drug prices, selling Allergan to rival AbbVie for $63 billion, why his best career decision was taking a "huge" pay cut and what's coming next for him after the AbbVie deal.
 Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

CEO Spotlight on Allergan's Brent Saunders

Every week, we feature the best and most interesting interviews from Bloomberg's daily market close show, "What'd You Miss" hosted by Joe Weisenthal, Caroline Hyde and Romaine Bostick. We want to take you beyond the headlines and bring you a unique perspective on the week's top stories, and those you may just have missed. It's the perfect way to kick off your weekend.

Share CEO Spotlight on Allergan's Brent Saunders

Sign up to save your podcasts

CEO Spotlight on Allergan's Brent Saunders

CEO Spotlight on Allergan's Brent Saunders